Clinical Trial Update: Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers [Phase 3]

View source ↗

Summary

A Phase 3 trial reports the immunogenicity and safety of a booster dose of Poliorix, an inactivated poliovirus vaccine, in toddlers who have been previously vac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Poliorix (inactivated poliovirus vaccine (IPV))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Poliomyelitis | Phase 3 | Status: COMPLETED | Results posted: 2016-12-07